A comparative pharmaceutical and analytical study of Shirisharishta prepared by Twak, Sara and Kastha from Shirisha
Pain R.1*, Vidyarani M.2
DOI: http://dx.doi.org/10.21760/jaims.7.10.21
1* Rajdeep Pain, Post Graduate Scholar, Department of Rasa Shastra and Bhaisajya Kalpana, Ramakrishnna Ayurvedic Medical College Hospital and Research Centre, Bengaluru, Karnataka, India.
2 M. Vidyarani, Professor & H.O.D, Department of Post Graduate Studies in Rasa Shastra and Bhaishajya Kalpana, Ramakrishnna Ayurvedic Medical College Hospital and Research Centre, Bengaluru, Karnataka, India.
Shirisha (Albizzia lebbeck Benth.) is well known classical drug used for the treatment of various types of diseases such as Shwasa, Kasa, Shosh etc. In this study 3 different sample of Shirisharista prepared from 3 different main ingredient Twak Sara and Kastha along with herbs like Pippali Priyangu etc. Shirisharishta is one such formulation mentioned under Visha Chikitsa, which is in use as a mode of Shaman Chikitsa. The reference of this Yoga is adopted from Bhaishajya Ratnavali. To formulate Shirisharista from Twak, Sara and Kastha from Shirisha and evaluate their pharmaceutical and analytical characteristics. Shirisharishta was prepared from Twak Sara and Kastha of A. lebbeck. Organoleptic characterization pH, specific gravity, total solid content, alcohol content and TLC profile of the prepared 3 samples were determined. Heartwood is the best part of use of A. lebbeck for preparation of Shirisharishta.
Keywords: Shirisha, Shirisharishta, Twak Sara, Kastha
Corresponding Author | How to Cite this Article | To Browse |
---|---|---|
Email: |
, Post Graduate Scholar, Department of Rasa Shastra and Bhaisajya Kalpana, Ramakrishnna Ayurvedic Medical College Hospital and Research Centre, Bengaluru, Karnataka, India.Rajdeep Pain, M. Vidyarani, A comparative pharmaceutical and analytical study of Shirisharishta prepared by Twak, Sara and Kastha from Shirisha. J Ayu Int Med Sci. 2022;7(10):165-174. Available From https://www.jaims.in/jaims/article/view/2130 |